Publisher
Proceedings of the National Academy of Sciences
Reference4 articles.
1. FDA (2011) FDA news release: “FDA approves Adcetris to treat two types of lymphoma.” Available at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm268781.htm. Accessed September 15, 2012.
2. Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
3. Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
4. FDA (2010) FDA news Release: “Pfizer voluntarily withdraws cancer treatment Mylotarg from U.S. market.” Available at www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm216448.htm. Accessed September 15, 2012.
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献